ChemoCentryx's change in receivables for the quarter that ended in Jun. 2022 was $-2.14 Mil. It means ChemoCentryx's Accounts Receivable
increased by $2.14 Mil
from Mar. 2022 to Jun. 2022 .
ChemoCentryx's change in receivables for the fiscal year that ended in Dec. 2021 was $-0.29 Mil. It means ChemoCentryx's Accounts Receivable
increased by $0.29 Mil
from Dec. 2020 to Dec. 2021 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
ChemoCentryx's Days Sales Outstanding for the
three
months ended in Jun. 2022 was 38.37.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. ChemoCentryx's liquidation value for the
three
months ended in Jun. 2022 was $152.20 Mil.
ChemoCentryx Change In Receivables Historical Data
The historical data trend for ChemoCentryx's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoCentryx (NAS:CCXI) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
ChemoCentryx's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoCentryx Change In Receivables Related Terms
Thank you for viewing the detailed overview of ChemoCentryx's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
ChemoCentryx Inc is a biopharmaceutical company involved in the discovery, development, and commercialization of orally administered drugs to treat rare diseases, inflammatory disorders, autoimmune diseases, and cancer. The company's approach is to target the chemoattractant system, defined as a network of molecules (for example, chemokine ligands, their associated receptors, and chemoattractant receptors) known to cause inflammation. The targeted therapeutic areas are an antineutrophil cytoplasmic antibody, atypical hemolytic uremic syndrome, immunoglobulin A-mediated nephropathy (rare diseases category), pancreatic cancer, chronic kidney disease, psoriasis, rheumatoid arthritis, asthma, Crohn's disease, inflammatory bowel disease, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCXI has been successfully added to your 